Intraoperative Awareness
From Ether Day to THRIVE
George A. Mashour, M.D., Ph.D.
Robert B. Sweet Professor & Chair, Department of Anesthesiology
Professor of Neurosurgery & Pharmacology
Faculty, Neuroscience Graduate Program
University of Michigan Medical School, Ann Arbor
No conflicts of interest to declare
“Suffering so great as I
underwent cannot be
expressed in words… but
the blank whirlwind of
emotion, the horror of great
darkness, and the sense of
desertion by God and man,
which swept through my
mind, and overwhelmed my
heart, I can never forget.”
“During the operation the patient
muttered, as in a semi-conscious state,
and afterwards stated that the pain was
considerable though mitigated… There
was, probably, in this instance, some
defect in the process of inhalation…”
Outline
Definition
Incidence & risk factors
Sequelae
Prevention
Outline
Definition
Incidence & risk factors
Sequelae
Prevention
Defining the problem
“Awareness”
Defining the problem
“Awareness” = Consciousness + Memory
Defining the problem
“Awareness” = Consciousness + Memory
Consciousness = Arousal +
Defining the problem
“Awareness” = Consciousness + Memory
Consciousness = Arousal + Experience
Defining the problem
“Awareness” = Consciousness + Memory
Memory => Explicit Episodic Recall
4.6% (12/260 patients) had positive response
but no postoperative recall; inhaled anesthetic (after
induction, before intubation) appears protective
What does this mean for THRIVE?
The group randomized to TIVA with no
post-induction inhaled agent might be
at higher risk of intraoperative
awareness without recall
Outline
Definition
Incidence & risk factors
Sequelae
Prevention
Incidence of the problem in the
United States
Incidence of 25/19,575 or 0.13%
Sebel et al, Anesth Analg, 2004;99:833
…consistent with a prospective
study in Sweden
Incidence of 19/11,785 or 0.16%
Sandin et al, Lancet, 2000;355:707
…consistent with a prospective
study in Sweden
Incidence of 19/11,785 or 0.16%
Note that incidence with NMB was higher
Sandin et al, Lancet, 2000;355:707
not consistent with data from
another U.S. study
Incidence of 6/87,381 or 0.0068%
Pollard et al, Anesthesiology 2007:106:269
Comparing Brice interview to
quality assurance techniques
Mashour et al, Anesth Analg, 2013;116:889
Comparing Brice interview to
quality assurance techniques
Mashour et al, Anesth Analg, 2013;116:889
Spontaneous patient reports are not
sufficient for an accurate incidence of
this outcome
Any MPOG study including
intraoperative awareness will likely
have to involve enriched, prospective
data collection
What does this mean for THRIVE?
Mashour et al, Anesth Analg, 2010;110:813
Classifying awareness events
Classifying awareness events
Mashour et al, Anesth Analg, 2010;110:813
Classifying awareness events
Pandit et al, Br J Anaesth, 2014;113:560
High-risk cases
Cardiac
Hemorrhagic trauma/surgery
Cesarean section delivery
Difficult airway
Pediatric
TIVA
High-risk cases
Cardiac
Hemorrhagic trauma/surgery
Cesarean section delivery
Difficult airway
Pediatric
TIVA
TIVA is typically considered a high-risk
group for intraoperative awareness
with recall
THRIVE will be the first study to
compare TIVA to inhaled anesthesia
with awareness as an outcome
What does this mean for THRIVE?
Risk factors and causes
Ghoneim et al, Anesth Analg, 2009;108:527
Risk factors and causes
Ghoneim et al, Anesth Analg, 2009;108:527
Are patients with a history of
awareness:
Are patients with a history of
awareness:
At increased risk of awareness?
Are patients with a history of
awareness:
At increased risk of awareness?
Cared for differently by anesthesia
providers?
Are patients with a history of
awareness:
At increased risk of awareness?
Cared for differently by anesthesia
providers?
Less responsive to the effects of
general anesthetics?
26,490 patients from three major trials
were screened for history of awareness
26,490 patients from three major trials
were screened for history of awareness
26,490 patients from three major trials
were screened for history of awareness
26,490 patients from three major trials
were screened for history of awareness
Control group
Matched 5:1 for
Age
ASA physical status
Comorbid conditions
Risk factors for awareness
Increased incidence of awareness
with history of awareness
Aranake et al, Anesthesiology, 2013;119:1275
No difference in anesthetic care
Aranake et al, Anesthesiology, 2013;119:1275
0.4 0.80.6
1.0 1.2 1.4
Anesthetic concentration (aaMAC)
0
20
40
60
80
100
Bispectral Index
Altered MAC-BIS relationship
Controls
History of AWR
Controls
History of AWR
A proportion of patients screened for
THRIVE will have a substantially higher
risk of awareness
Clinicians are unlikely to change
practice as a result of that risk factor
What does this mean for THRIVE?
Outline
Definition
Incidence & risk factors
Sequelae
Prevention
Post-traumatic stress disorder
Elevated autonomic arousal and
generalized anxiety
Intrusive and distressing thoughts or
images recalling the trauma
Behavioral avoidance of physical cues
that prompt memory of the trauma
Incidence of post-awareness PTSD
Mashour, Anesth Analg, 2010;110:668
PTSD in 71%
Incidence of post-awareness PTSD
Mashour, Anesth Analg, 2010;110:668
Psychological Sequelae of
Surgery (Psych SOS) study
Awareness patients and matched controls
taken from B-Unaware, BAG-RECALL and
MACS trials
PCL-S self-report administered
43% with awareness met a screening
threshold for PTSD
Dissociation appeared to be a mediating
factor
Whitlock et al, Anesth Analg, 2015;120:87
Trial participants reporting awareness
should be made aware of the risk for
syndromal or subsyndromal PTSD
What does this mean for THRIVE?
Outline
Definition
Incidence & risk factors
Sequelae
Prevention
Major randomized controlled trials
B-Aware trial (2004)
B-Unaware trial (2008)
BAG-RECALL trial (2011)
BIS-TIVA trial (2011)
MACS (2012)
B-Aware trial
High-risk population, multicenter
Randomized to routine care or BIS
40-60
Confirmed awareness 0.17% (n=2) in
BIS compared to 0.91% (n=11) in
control (p=0.02)
Myles et al, Lancet, 2004;363:1757
B-Unaware trial
High-risk population, single center
Compared BIS 40-60 to MAC 0.7-1.3
2 cases of definite awareness in each
group (overall incidence of 0.21%)
Avidan et al, NEJM, 2008;358:1097
BAG-RECALL trial
High-risk population, multicenter
Elimination of “minor criteria”
Compared BIS 40-60 to age-adjusted
MAC 0.7-1.3
Avidan et al, NEJM, 2011;365:591
Outcomes
Avidan et al, NEJM, 2011;365:591
BIS-TIVA trial
High-risk population, multicenter
2919 TIVA cases randomized to BIS 40-
60, 2309 TIVA cases randomized to
routine care
Confirmed awareness 0.14% (n=4) in
BIS compared to 0.65% (n=15) in
control (p=0.002)
Zhang et al, Chin Med J, 2011;124:3664
MACS
All risk levels, multihospital, single
center
Randomized to real-time decision
support with alarms for BIS>60 or
“effective” MAC<0.5
Study terminated for futility after interim
analysis and recruitment of >20,000
patients
Mashour et al, Anesthesiology;2012:117:717
Primary outcome
Mashour et al, Anesthesiology;2012:117:717
Secondary outcome
Mashour et al, Anesthesiology;2012:117:717
Synthesizing the Trials
BIS is effective in reducing awareness
compared to routine care
and in patients
receiving TIVA
(B-Aware, 2004; Zhang-TIVA trial, 2011;
MACS, 2012)
BIS not superior compared to a MAC-
guided protocol
(B-Unaware, 2008; BAG-RECALL, 2011;
MACS 2012)
Avidan & Mashour, Anesthesiology, 2013;118:449
Mashour & Avidan, Br J Anaesth, 2015;115:i20
2014, 2019
Patients randomized to the TIVA group
would likely benefit from intraoperative
EEG monitoring to reduce risk of
intraoperative awareness with recall
What does this mean for THRIVE?
Summary
“Awareness” refers to arousal, experience,
and explicit episodic recall
Awareness occurs in approximately 1-2
cases/1000
Risk factors include high-risk anesthetics
and a history of awareness
PTSD occurs in a significant proportion of
patients experiencing awareness
BIS monitor is likely effective in
reducing awareness compared to
routine care and during TIVA
MAC protocol is a cost-effective
alternative in patients receiving volatile
anesthetics
Summary
Neural inertia
Emergence trajectories
EEG oscillations
Coherence, cross-frequency coupling,
connectivity
Cortical dynamics
Current Directions
Acknowledgments